Last reviewed · How we verify
5% Minoxidil
At a glance
| Generic name | 5% Minoxidil |
|---|---|
| Also known as | Minoxidil solution, Minoxidil lotion, Rogaine®, Theroxidil®, Minoxidil Topical |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Drug class | Central Nervous System Stimulant [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Androgenic Alopecia TH07 Clinical Trial (PHASE3)
- Topical Methotrexate vs Minoxidil for Localized Alopecia Areata (PHASE4)
- Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia (PHASE3)
- Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia (PHASE2)
- Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia (NA)
- Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia (PHASE2)
- Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia (PHASE3)
- A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 5% Minoxidil CI brief — competitive landscape report
- 5% Minoxidil updates RSS · CI watch RSS
- Second Affiliated Hospital, School of Medicine, Zhejiang University portfolio CI